vadimezan has been researched along with parthenolide in 1 studies
Studies (vadimezan) | Trials (vadimezan) | Recent Studies (post-2010) (vadimezan) | Studies (parthenolide) | Trials (parthenolide) | Recent Studies (post-2010) (parthenolide) |
---|---|---|---|---|---|
272 | 16 | 101 | 612 | 5 | 323 |
Protein | Taxonomy | vadimezan (IC50) | parthenolide (IC50) |
---|---|---|---|
Nitric oxide synthase, inducible | Mus musculus (house mouse) | 4.525 | |
Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baguley, BC; Ching, LM; Wang, LC; Woon, ST | 1 |
1 other study(ies) available for vadimezan and parthenolide
Article | Year |
---|---|
Inhibition of DMXAA-induced tumor necrosis factor production in murine splenocyte cultures by NF-kappaB inhibitors.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Cells, Cultured; Electrophoretic Mobility Shift Assay; Enzyme-Linked Immunosorbent Assay; Interferon-gamma; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction; Salicylates; Sesquiterpenes; Spleen; Tumor Necrosis Factor-alpha; Xanthones | 2006 |